Abbreviations
- CT:
-
computer tomography
- MR:
-
magnetic resonance
- MRI:
-
magnetic resonance imaging
- SI:
-
signal intensity
References
Aisen, A.M., Martel, W., Gabrielsen, T.O., Glazer, G.M., Brewer, G., Young, A.B., and Hill, G. (1985). Wilson Disease of the Brain: MR Imaging.Radiology 157:137–141.
Aoki, S., Okada, Y., Nishimura, K., Barkovich, A.J., Kjos, B.O., Brasch, R.C., and Norman, D. (1989). Normal Deposition of Brain Iron in Childhood and Adolescence: MR Imaging at 1.5 T.Radiology 172:381–385.
Barbosa, E.R., Comerlatti, L.R., Scalff, M., and Canelos, H.M. (1985) Degegeracao hepato-lenticular aspectos diagnosticos em 95 casos.Arq. Neuropsiq.43(3):234–242.
Barkovich, A.J. (1990). Hallervorden-Spatz Disease. In (A.J. Barkovich, ed)Pediatric Neuroimaging Vol. 1Contempory Neuroimaging, Raven Press, New York, 48–49.
Barnes, S., and Hurst, E.W. (1926). A further note on hepato-lenticular degeneration,Brain 49: 36–60.
Bisese, J.H., and Wang, A.M. (1994). Wilson disease. In (J.H. Bisese, and A.M. Wang, eds)Pediatric Cranial MRI, Springer-Verlag, New York: p. 133.
Bloemberger, N., and Morgan, L.O. (1961). Influence of copper on T1 and T2 relaxation timesJ. Chem. Phys. 34:842.
Brewer, G.J., Terry, C.A., Aisen, A.M., and Hill, G.M. (1987). Worsening of neurological syndrome in patients with Wilson's Disease with initial penicillamine therapy.Arch. Neurol. 44:490–492.
Brewer, G.J., Yuzbasiyan-Gurkan, V., Lee, D.Y., and Appelman, H. (1989). Treatment of Wilson's disease with zinc. VI. Initial treatment studies.J. Lab. Clin. Med. 114(6):633–638.
Brewer, G.J., and Yuzbasiyan-Gurkan, V. (1992). Wilson Disease.Medicine 71:139–164.
Brewer, G.J., Dick, R.D., Johnson, V., Wang, Y., Yuzbasiyan-Gurkan, V., Kluin, K., Fink, J.K., and Aisen, A. (1994). Treatment of Wilson's Disease with ammonium tetrathiomolybdate.Arch. Neurol. 51:545–554.
Brewer, G.J. (1995). Treatment of neurologic manifestations of Wilson's disease (letter).Arch. Neurol. 52:340
Brugeries, P., Combes, C., Ricolfi, F., Degos, J.D., Poirier, J., and Gaston A. (1992). Atypical MR presentation of Wilson disease: a possible consequence of paramagnetic effect of copper?Neuroradiology 34:222–224.
Bull, P.C., Thomas, G.R., Rommens, J.M., Forbes, J.R., and Cox, D.W. (1993). The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene.Nat. Genet. 5:327–337.
Carpenter, TO, Carnes, DL, and Constantine, S. (1983). Hypoparathyroidism in Wilson's disease.N. Engl. J. Med. 309:873–877.
Cartwright, G.E., Hodges, R.E., Gubler, C.J., Mahoney, J., Wintrobe, M.M., and Bean W.B. (1954). Studies on copper metabolism. XIII. Hepatolenticular degeneration.J. Clin. Invest. 33: 1487–1501.
Chen, X.R., Shen, T.Z., Li, N.Z., and Liu, D.K. (1983). Computed tomography in hepatolenticular degeneration (Wilson's disease).Comput. Radiol. 7(6):361–364.
Chu, N.S. (1989). Clinical, CT and evoked potential manifestations in Wilson's disease with cerebral white matter involvement.Clin. Neurol. Neurosurg.,91(1):45–51.
Cumings, J.N. (1948). The copper and iron content of brain and liver in the normal and in hepatolenticular degeneration.Brain 71:410–415.
Cumings, J.N. (1968). Trace metals in the brain and Wilson's disease.J. Clin. Pathol. 21:1–7.
Czlonkowska, A., Gajda, J., and Rodo, M. (1995). Comparison of the effect of treatment in Wilson's disease with d-penicillamine and zinc sulphate as an initial therapy (abstract).Z. Gastroenterol. 33:479.
Danks, D.M. (1989). Disorders of copper transport. In (C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, eds). The Metabolic Basis of Inherited Disease, McGraw Hill Information Services Company, New York, pp. 1411–1421.
Detorri, P., Rachele, M.G., and Demelia, L. (1984). Computerized cranial tomography in presymptomatic and hepatic form of Wilson's disease.Eur. Neurol. 23(1):56–63.
De Haan, J., Grossman, R.I., Civitello, L., Hackney, D.B., Goldberg, H.I., Bilaniuk, L.T., and Zimmerman, R.A. (1987). High-field magnetic resonance imaging of Wilson's disease.J. Comput. Tomography 11:132–135.
Dixon, A.K., and Walshe, J.M. (1984). Computed tomography of the liver in Wilson's disease.J. Comput. Assisted Tomography 8(1):46–49.
Dornemann, H., Petsch, R., and Braitinger, S. (1987). MRI bei Morbus Wilson.Fortschr. Rontgenstr. 147(5):570–571.
Drayer, B.P. (1989). Basal ganglia: significance of signal hypointensity on T2-weighted MR images.Radiology 173:311–312.
Drayer, B.P. (1995). Degenerative disorders of the central nervous system: an integrated approach to the differential diagnosis.Neuroimaging Clin. North Am. 5(1):135–153.
Duchen, L.W., and Jacobs, J.M. (1992). Familial hepatolenticular degeneration (Wilson's disease). In (J.H. Adams, and L.W. Duchen, eds.),Greenfield's Neuropathology, 5th ed., Edward Arnold, London, pp. 838–841.
Earl, C.J. (1961). Anatomical distribution of copper in the brain. In. (J.M. Walshe and J.N. Cummings, eds)Wilson's Disease: Some Current Concepts. Blackwell Oxford: pp. 18–23.
Engelbrecht, V., Schlaug, G., Hefter, H., Kahn, T., and Modder U. (1995). MRI of the Brain in Wilson Disease. T2 Signal Loss Under Therapy.J. Comput. Assisted Tomography 19(4):635–638.
Feng, Y.K. (1957). Wilson's disease. Report of ten cases.Clin. Med. J. 75:631–655.
Frydman, M., Bonne-Tamir, B., Farrer, L.A., Conneally, M., Magazanik, A., Ashbel, S., and Goldwitch, Z. (1985). Assignment of the gene for Wilson disease to chromosome 13: Linkage to the esterase D locus.Proc. Natl. Acad. Sci. USA 82:1819–1821.
Glass, J.D., Reich, S.G., and DeLong, M.R. (1990). Wilson's Disease. Development of Neurological Disease After Beginning Penicillamine Therapy.Arch. Neurol. 47:595–596.
Greenfield, J.G., Polynton, F.J., and Walshe, F.M.R. (1924). On progressive lenticular degeneration (hepatolenticular degeneration).Q. J. Med. 17:385–403.
Grimm, G., Prayer, L., Oder, W., Ferenci, P., Madi, Ch., Knoflach, P.,et al. (1991). Comparison of functional and structural brain disturbances in Wilson's disease.Neurology 41: 272–276.
Harik, S.I., and Donvan Post, J. (1981). Computed tomography in Wilson disease.Neurology 31:107–110.
Hawkins, R.A., Mazziotta, J.C., and Phelps, M.E. (1987). Wilson disease studied with FDG and positron emission tomography.Neurology 37:1707–1711.
Hefter, H., Rautenberg, W., Kreuzpaintner, G., Arendt, G., Freund, H.-J., Pichlmayr, R., and Strohmeyer, G. (1991). Does orthotopic liver transplantation heal Wilson's disease? Follow-up of two liver-transplanted cases.Acta Neurol. Scand. 84:192–196.
Heier, L.A., Bauer, C.J., Schwartz, L., Zimmerman, R.D., Morgello, S., and Deck, M.D.F. (1989). Large Virchow-Robin spaces: MR-clinical correlation.Am. J. Neuroradiol. 10:929–936.
Hitoshi, S., Iwata, M., and Yoshikawa, K. (1991). Mid-brain pathology of Wilson's disease: MRI analysis of three cases.J. Neurol. Neurosurg. Psychiatry 54:624–626.
Hock, A., Demmel, U., Schicha, H., Kasperek, K., and Feinendegen, L.E. (1975). Trace element concentration in human brain.Brain 98:49–64.
Hoogenraad, T.U., and Rothuizen, J. (1986). Compliance in Wilson's disease and in copper toxicosis of Bedlington terriers (letter).Lancet 2:170.
Hoogenraad, T.U., Van Hattum, J., and Van den Hamer, C.J.A. (1987). Management of Wilson's disease with zinc sulphate: experience in a series of 27 patients.J. Neurol. Sci. 77:137–146.
Hoogenraad, T.U. (1996).Major Problems in Neurology, Vol. 30Wilson's Disease. W. B. Saunders Company, London.
Horoupian, D.S., Sternlieb, I., and Scheinberg, I.H. (1988). Neuropathological findings in penicillamine-treated patients with Wilson's disease.Clin. Neuropathol. 7(2):62–67.
Houwen, R.H.J. (1991). Wilson disease from clinical to molecular (Dissertation University of Gronningen) Elinkwijk: Utrecht.
Huang, C.C., and Chu, N.S. (1992). Resolution of cerebral white matter lesions following long-term penicillamine therapy for Wilson disease report of a case.J. Formosan. Med. Assoc. 91(6):627–629.
Imiya, M., Ichikawa, K., Matsushima, H., Kageyama, Y., and Fujioka, A. (1992). MR of the base of the pons in Wilson Disease.Am. J. Neuroradiol. 13:1009–1012.
Ishino, H., Takashi, M., Hayashi, Y., Saito, A., and Otsuki, S. (1972). A case of Wilson's disease with enormous cavity formation of cerebral white matter.Neurology 22:905–909.
Kendall, B.E., Pollock, S.S., Bass, N.M., and Valentine, A.R. (1981). Wilson's Disease: Clinical Correlation with Cranial Computed Tomography.Neuroradiology 22:1–5.
Kvicala, V., Vymazai, J., and Nevsimalova, S. (1983). Computed tomography of Wilson disease.Am. J. Neuroradiol. 4:429–430.
Lang, C.J.G., Rabas-Kolominsky, P., Engelhardt, A., Kobras, G., and Konig, H.J. (1993) Fatal deterioration of Wilson's Disease after institution of oral zinc therapy (letter).Arch. Neurol. 50:1007–1008.
Lawler, G.A., Pennock, J.M., Steiner, R.E., Jenkins, W.J., Sherlock, S., and Young, I.R. (1983). Nuclear Magnetic Resonance (NMR) Imaging in Wilson Disease.J. Comp. Ass. Tomography 7 (1):1–8.
Le Fort, D., Deleplanque, B., Louiset, P., Pautrizel, B., and Loiseau, P. (1988). Maladie de Wilson: Demonstration de lesions corticales et de la substance blanche par IRM.Rev. Neurol. (Paris) 144(5): 365–367.
Leu, M.L., Strickland, G.T., Wang, C.C., and Chen, T.S.M. (1970). Skin pigmentation in Wilson's disease.J.A.M.A. 211:1542–1543.
Linne, T., Agartz, I., Saaf, J., and Wahlund, L.O. (1990). Cerebral abnormalities in Wilson's disease as evaluated by ultra-low-field magnetic resonance imaging and computerized image processing.Magn. Reson. Imaging 8:819–824.
Lingam, S., Wilson, J., Nazer, H., and Mowat, A.P. (1987). Neurological Abnormalities in Wilson's Disease are reversible.Neuropediatrics 18:11–12.
Lukes, S.A., Aminoff, M.J., Crooks, L., Kaufman, L., Mills, C., and Newton, T.H. (1983). Nuclear magnetic resomance imaging in movement disorders.Ann. Neurol. 13(6):690–691.
Luxenberg, M.N. (1987). Magnetic Resonance imaging diagnosis of hepatolenticular degeneration.Arch. Ophthalmol. 105:227.
Ma, K.C., Ye, Z.R., Fang, J., and Wu, J.V. (1988). Glial fibrillary acidic protein immunohistochemical study of Alzheimer I and II astrogliosis in Wilson's disease.Acta Neurol. Scand. 78:290–296.
Magalhaes, A.C.A., Caramelli, P., Menezes, J.R., Lo, L.S., Bacheschi, L.A., Barbosa, E.R., Rosemberg, L.A., and Magalhaes, A. (1994). Wilson's disease: MRI with clinical correlation.Neuroradiology 36:97–100.
Marsden, C.D. (1987). Wilson's disease.Q. J. Med. 65:959–966.
Mason, A.L., Marsh, W., and Alpers, D.H. (1993). Intractable neurological Wilson's Disease treated with orthotopic liver transplantation.Dig. Dis. Sci. 38 (9):1746–1750.
Merland, J.J., Chiras, J., and Melki, J.P. (1978). Etude tomodensitometrique dans la maladie de Wilson.Neuroradiology,16:269–270.
Metzer, W.S., and Angtuaco, E. (1986). Long-term followup computed tomography and magnetic resonance imaging findings in hepatolenticular degeneration: Case report and summary of the literature.Mov. Disord. 1(2):145–149.
Mirowitz, S.A., Sartor, K., and Gado, M. (1989). High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.Am. J. Neuroradiol. 10:1159–1163.
Mirowitz, S.A., Westrich, T.J., and Hirsch, J.D. (1991). Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition.Radiology 181:117–120.
Mizutani, N., Maehara, M., Negora, T., Watanabe, K. (1983) Serial changes of cranial computerized tomographic findings in Wilson Disease during D-Penicillamine therapy.Brain Dev.,5(1):48–52.
Mzhe'lskaia, T.I. (1989) Analysis of trace elements of the brain and liver tissues in Wilson disease (abstract).Zh. Neuropatol. Psikhiatr. 89(7):69–73.
Nalbandyan, R.M. (1983). Copper in Brain.Neurochem. Res. 8(10):1211–1232.
Nazer, H., Brismar, J., Al-Kawi, M.Z., Gunasekaran, T.S., and Jorulf, K.H. (1993). Magnetic resonance imaging of the brain in Wilson's disease.Neuroradiology 35:130–133.
Nelson, R.F., Guzman, D.A., Grahovac, Z., and Howse, D.C.N. (1979). Computerized cranial tomography in Wilson disease.Neurology 29:866–868.
Nix, W.A., Ludwig, G., and Backmund, H. (1984). Computertomographische Verlaufsuntersuchungen bei Morbus Wilson.Nervenartz 55(10):544–548.
Oder, W., Prayer, L., Grimm, G., Spatt, J., Ferenci, P., Kollegger, H., Schneider, B., Gangl A., Deecke, L. (1993). Wilson disease: evidence of subgroups derived from clinical findings and brain lesions.Neurology 43:120–124.
Oertel, W.H., Tatsch, K., Schwartz, J., Kraft, E., Trenkwalder, C., Scherer, J., Weinzierl, M., Vogl T., and Kirsch, C.M. (1992). Decrease of D2 receptors indicated by123I-Iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease.Ann. Neurol. 32:743–748.
Pomier-Layrargues, G., Spahr, L., and Butterworth, R.F. (1995). Increased manganese concentrations in pallidum of cirrhotic patients (letter).Lancet 345:735.
Porter, H., and Folch, J. (1957). Brain copper-protein fractions in the normal and in Wilson's Disease.Arch. Neurol. 77:8–16.
Prayer, L., Wimberger, D., Kramer, J., Grimm, G., Oder, W., and Imhof, H. (1990). Cranial MRI in Wilson disease.Neuroradiology 32:211–214.
Pujol, A., Pujol, J., Graus, F., Rimola, A., Peri, J., Mercader, J.M., Garcia-Pagan, J.C., Bosch, J., Rodes, J., and Tolosa, E. (1993). Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure.Neurology 43:65–69.
Roach, E.S., Ford, C.S., and Soudis, E.V. (1985). Wilson's disease: evoked potentials and computed tomography.J. Neurol. 232(1):20–23.
Rodiek, S. (1983). Zerebrale Lasionen bie Morbus Wilson im Computertomogramm.Fortschr. Rontgenstr. 139(1):67–71.
Roh, J.K., Lee, T.G., Wie, B.A., Lee, S.B., Park, S.H., and Chang, K.H. (1994). Initial and follow-up brain MRI findings and correlation with the clinical course of Wilson disease.Neurology 44: 1064–1068.
Ropper, A.H., Hatten, H.P., and Davis, K.R. (1979). Computed tomography in Wilson Disease: Report of 2 cases.Ann. Neurol. 5(1):102–103.
Roselli, M. (1987). Wilson's disease, a reversible dementia: case report.J Clin. Exp Neuropsychol 9(4): 399–406.
Rothfus, W.E., Hirsch, W.L., Malatack, J.J., and Bergman, I. (1988). Improvement of cerebral CT abnormalities following liver transplatation in a patient with Wilson Disease.J. Comput. Assisted Tomography 12(1):138–140.
Scheinberg, I.H., and Sternlieb, I. (1984).Major Problems in Internal Medicine, Vol. XXIII:Wilson's Disease, W. B. Saunders Company, Philadelphia.
Scheinberg, I.H., and Sternlieb, I. (1995). Treatment, of neurologic manifestations of Wilson's disease (letter).Arch. Neurol. 52:339–340.
Selekler, K., Kansu, T., and Zileli, T. (1981) Computed tomography in Wilson Disease.Arch. Neurol. 38: 727–728.
Sener, R.N. (1993). The claustrum on MRI: normal anatomy, and the bright claustrum as a new sign in Wilson's disease.Pediatr. Radiol. 23:594–596.
Shiraki, H. (1968). Comparative neuropathologic study of Wilson's Disease and other types of hepatocerebral disease.Birth Defects IV(2):64–73.
Shoulson, I., Goldblatt, D., Plassche, W., and Wilson, G. (1983). Some therapeutic observations in Wilson's Disease.Adv. Neurol. 37:239–245.
Singcharoen, T., Chakkaphak, K., and Udompanich, O. (1991). Unusual magnetic resonance findings in Wilson's disease.Br. J. Radiol. 64:752–754.
Smith, F.W., Gemell, H.G., Sharp, P.F., and Besson J.A.O. (1988). Technetium-99m HMPAO imaging in patients with basal ganglia disease.Br. J. Radiol. 61:914–920.
Snow, B.J., Bhatt, M., Martin, W.R.W., Li, D., and Calne, D.B. (1991). The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.J. Neurol. Neurosurg. Psychiatry 54:12–17.
Starosta-Rubinstein, S., Young, A.B., Kluin, K., Hill, G., Aisen, A.M., Gabrielsen, T., and Brewer, G.J. (1987). Clinical assessment of 31 patients with Wilson's Disease.Arch. Neurol. 44:365–370.
Sternlieb, I. (1990). Perspectives on Wilson's disease.Hepatology 12(5):1235–1239.
Takano, K., Kuroiwa, Y., Shimada, Y., Mannen, T., and Toyokura Y. (1983). CT manifestations of cerebral white matter lesion in Wilson Disease.Ann. Neurol. 13(1):108–109.
Tallis, G.A., Kitchener, M.I., and Thomas, A.C. (1990). Hyperparathyroidism in a patient with Wilson's disease.Clin. Chem. 36(3):568–570.
Tanzi, R.E., Petrukhin, K., Chernow, I., Pellequer, J.L., Wasco, W., Ross, B., Romano, D.M., Parano, E., Pavone, L., Brzustowicz, L.M., Devoto, M., Peppercorn, J., Bush, A.I., Sternlieb, I., Pirastu, M., Gusella, J.F., Evgrafov, O., Penchaszadeh, G.K., Honig, B., Edelman, I.S., Soares, M.B., Scheinberg, I.H., and Gilliam, T.C. (1993). The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene.Nat. Genet. 5:344–350.
Thuomas, K.A., Aquilonius, S.M., Bergstrom, K., and Westermark, K. (1993). Magnetic resonance imaging of the brain in Wilson disease.Neuroradiology 35:134–141.
Tingey, A.H. (1937). The iron, copper and manganese content of the human brain.J. Ment. Sci. 83:452–460.
Uzman, L.L. (1956). Histochemical localization of copper with rubeanic acid.Lab. Invest. 5(3):299–305.
Van den Berg, J.S.P., Hoogenraad, T.U., Duyn, J.A., Verbeeten, jr. B., Aalfs, C.M., and De Visser, M. (1995). Ziekte van Wilson: ontmaskering met behulp van kernspinresonantie-tomography.,Ned. Tijdschr Geneeskd. 139(15):796–799.
Van den Heuvel, A.G., Van Wassenaer-van Hall, H.N., Hoogenraad, T.U., Mali, W.P.T.M. (1995). Hepatic or copper related encephalopathy in Wilson's disease: can MR differentiate between them? (abstract).Eur. Radiol. 5 (suppl.) S140.
Van der Knaap, M.S., and Valk, J. (1995). Wilson Disease. In (M.S. Van der Knaap, and J. Valk, eds.),Magnetic Resonance of Myelin, Myelination and Myelin Disorders (2nd ed.), Springer-Verlag, Berlin, pp. 246–251.
Van Wassenaer-van Hall, H.N., Van den Heuvel, A.G., Jansen, G.H., Hoogenraad, T.U., and Mali, W.P.T.M. (1995). Cranial MR in Wilson Disease: Abnormal white matter in extrapyramidal and pyramidal tracts.Am. J. Neuroradiol. 16:2021–2027.
Van Wassenaer-van Hall, H.N., Van den Heuvel, A.G., Algra, A., Hoogenraad, T.U., and Mali, W.P.T.M. (1996a). Wilson Disease: Findings at MR imaging and CT of the Brain with Clinical Correlation.Radiology 198:531–536.
Van Wassenaer-van Hall, H.N., Van den Heuvel, A.G., Hoogenraad., T.U., and Mali, W.P.T.M. (1996b). Wilson disease: Long-term follow-up with brain MRI during zinc therapy. In:Wilson Diseae: Magnetic Resonance Findings (Dissertation, University of Utrecht), Feba Druk DV, Enschede: pp. 39–50.
Victor, M. (1974). Neurologic changes in liver disease. In (F. Plum, ed.),Brain Dysfunction in Metabolic Disorders, Vol. 53, Raven Press, New York, pp. 1–12.
Vymazal, J., Bulte, J.W.M., Frank, J.A., Di Chiro, G., and Brooks, R.A. (1993). Frequency dependence of MR relaxation times I. Paramagnetic ions.J. Magn. Reson. Imaging. 3:637–640.
Walshe, J.B. (1986). Wilson's disease. In (P.J. Vinken, G.W. Bruyn, H.L. Klawans, eds),Handbook of Clinical Neurology, Vol. 5 (49), Elsevier, New York, 223–238.
Walshe, J.M., and Gibbs, K.R. (1987). Brain copper in Wilson's disease (letter).Lancet 2:1030.
Walshe, J.M., and Yealland, M. (1993). Chelation treatment of neurological Wilson's disease.Q. J. Med. 86:197–204.
Warren, P.J., Earl, C.J., and Thompson, R.H.S. (1960). The distribution of copper in the human brain.Brain 83:709–717.
Willeit, J., Kieschl, S.G., Birbamer, G., Schmidauer, Ch., Felber, St., Aichner, F., Saltvari, L., Metzler, R., and Judmaier, G. (1992). Morbus Wilson mit primarer ZNS-manifestation—aktueller stand in diagnostik and therapy.Fortschr. Neurol. Psychiat. 60:237–245.
Williams, J.B., and Walshe, J.M. (1981). Wilson's disease: an analysis of the cranial computerized tomography appearances found in 60 patients and the changes in response to treatment with chelating agents.Brain 104:735–752.
Wilson, S.A.K. (1912). Progressive lenticular degeneration. A familial nervous disease associated with cirrhosis of the liver.Brain 34:295–507.
Yuh, W.T.C. and Flickinger, F.W. (1988). Unusual MR findings in CNS Wilson disease (letter).Am. J. Roentgenol. 151:834.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Wassenaer-van Hall, H.N. Neuroimaging in Wilson disease. Metab Brain Dis 12, 1–19 (1997). https://doi.org/10.1007/BF02676350
Issue Date:
DOI: https://doi.org/10.1007/BF02676350